Iovance Biotherapeutics
IOVA
IOVA
87 hedge funds and large institutions have $461M invested in Iovance Biotherapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
Holders
87
Holders Change
+2
Holders Change %
+2.35%
% of All Funds
1.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
33
Reduced
24
Closed
12
Calls
$942K
Puts
$345K
Net Calls
+$597K
Net Calls Change
+$673K
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$5.2M |
2 |
O
2
OrbiMed
New York
|
$44.4M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$401K |
4 |
4
Victory Capital Management
San Antonio,
Texas
|
$16.8M |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$10.1M |